Answers are grounded in this paper and cite their sources.
Tracking ex vivo radiolabeled cells using radionuclide imaging such as positron emission tomography is an emerging method for evaluating cell-based therapies. Traditional radiolabeling requires a centrifuge in multiple steps to optimize labeling and remove unbound radiotracers. With the goal of automating the radiolabeling procedure, we explored an acoustophoresis-based approach for radiolabeling cells, eliminating the need of using a centrifuge, simplifying the design of this future device. The AcouWash 2 (AcouSort AB, Lund, Sweden), an acoustophoresis based cell washing device, was evaluated for its ability to label EL4 murine T lymphoblasts with zirconium-89 ( 89 Zr)-oxine without centrifugation. The AcouWash 2 successfully replaced the culture medium with a protein-free buffer, as required for 89 Zr-oxine cell labeling. Additionally, it was able to concentrate EL4 cells by a factor of 5.6 ± 0.4, achieving or exceeding the optimal labeling cell density. After cell incubation with 89 Zr-oxine, AcouWash 2 exchanged the incubation solution with a solution for infusion, removing unbound 89 Zr-oxine. These steps eliminated the need for centrifugation at each stage of the labeling procedure. The resulting radiolabeled EL4 cells exhibited labeling metrics, specific activity, percent labeling efficiency, percent free 89 Zr-oxine in the suspension buffer and cell viability, comparable to those obtained from conventional centrifuge-based method. Our results demonstrate that the radiolabeling can be performed entirely using acoustophoresis, which paves the way for developing a fully automated radiolabeling device based on acoustophoresis technology.
No takes yet. Share an insight, caveat, or question.
Adler et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: